Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 147

1.

Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor.

Thysell E, Vidman L, Ylitalo EB, Jernberg E, Crnalic S, Iglesias-Gato D, Flores-Morales A, Stattin P, Egevad L, Widmark A, Rydén P, Bergh A, Wikström P.

Mol Oncol. 2019 Jun 4. doi: 10.1002/1878-0261.12526. [Epub ahead of print]

2.

Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome.

Hammarsten P, Josefsson A, Thysell E, Lundholm M, Hägglöf C, Iglesias-Gato D, Flores-Morales A, Stattin P, Egevad L, Granfors T, Wikström P, Bergh A.

Mod Pathol. 2019 Apr 12. doi: 10.1038/s41379-019-0260-6. [Epub ahead of print]

PMID:
30980038
3.

PKCζ facilitates lymphatic metastatic spread of prostate cancer cells in a mice xenograft model.

Zang G, Mu Y, Gao L, Bergh A, Landström M.

Oncogene. 2019 May;38(22):4215-4231. doi: 10.1038/s41388-019-0722-9. Epub 2019 Jan 31.

PMID:
30705401
4.

Prostate cancer induces C/EBPβ expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome.

Adamo H, Hammarsten P, Hägglöf C, Dahl Scherdin T, Egevad L, Stattin P, Halin Bergström S, Bergh A.

Prostate. 2019 Apr;79(5):435-445. doi: 10.1002/pros.23749. Epub 2018 Dec 11.

PMID:
30536410
5.

The Proteome of Prostate Cancer Bone Metastasis Reveals Heterogeneity with Prognostic Implications.

Iglesias-Gato D, Thysell E, Tyanova S, Crnalic S, Santos A, Lima TS, Geiger T, Cox J, Widmark A, Bergh A, Mann M, Flores-Morales A, Wikström P.

Clin Cancer Res. 2018 Nov 1;24(21):5433-5444. doi: 10.1158/1078-0432.CCR-18-1229. Epub 2018 Jul 24.

PMID:
30042207
6.

Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.

Nordstrand A, Bovinder Ylitalo E, Thysell E, Jernberg E, Crnalic S, Widmark A, Bergh A, Lerner UH, Wikström P.

Int J Mol Sci. 2018 Apr 18;19(4). pii: E1223. doi: 10.3390/ijms19041223.

7.

Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness.

Bergström SH, Järemo H, Nilsson M, Adamo HH, Bergh A.

Prostate. 2018 Mar;78(4):257-265. doi: 10.1002/pros.23466. Epub 2017 Dec 18.

PMID:
29250809
8.

Pro-invasive properties of Snail1 are regulated by sumoylation in response to TGFβ stimulation in cancer.

Gudey SK, Sundar R, Heldin CH, Bergh A, Landström M.

Oncotarget. 2017 Aug 9;8(58):97703-97726. doi: 10.18632/oncotarget.20097. eCollection 2017 Nov 17.

9.

A Systems Approach to Prostate Cancer Classification-Letter.

Thysell E, Ylitalo EB, Jernberg E, Bergh A, Wikström P.

Cancer Res. 2017 Dec 15;77(24):7131-7132. doi: 10.1158/0008-5472.CAN-16-3231. Epub 2017 Dec 6. No abstract available.

10.

Highly aggressive rat prostate tumors rapidly precondition regional lymph nodes for subsequent metastatic growth.

Strömvall K, Lundholm M, Thysell E, Bergh A, Halin Bergström S.

PLoS One. 2017 Oct 26;12(10):e0187086. doi: 10.1371/journal.pone.0187086. eCollection 2017.

11.

Prostate Cancer Detection with a Tactile Resonance Sensor-Measurement Considerations and Clinical Setup.

Åstrand AP, Andersson BM, Jalkanen V, Ljungberg B, Bergh A, Lindahl OA.

Sensors (Basel). 2017 Oct 26;17(11). pii: E2453. doi: 10.3390/s17112453.

12.

Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening.

Assel M, Dahlin A, Ulmert D, Bergh A, Stattin P, Lilja H, Vickers AJ.

Eur Urol. 2018 Jun;73(6):961-967. doi: 10.1016/j.eururo.2017.10.004. Epub 2017 Oct 21.

13.

Clinical relevance of androgen receptor alterations in prostate cancer.

Jernberg E, Bergh A, Wikström P.

Endocr Connect. 2017 Nov;6(8):R146-R161. doi: 10.1530/EC-17-0118. Review.

14.

Reduced number of CD169+ macrophages in pre-metastatic regional lymph nodes is associated with subsequent metastatic disease in an animal model and with poor outcome in prostate cancer patients.

Strömvall K, Sundkvist K, Ljungberg B, Halin Bergström S, Bergh A.

Prostate. 2017 Nov;77(15):1468-1477. doi: 10.1002/pros.23407. Epub 2017 Sep 7.

15.

TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α.

Hamidi A, Song J, Thakur N, Itoh S, Marcusson A, Bergh A, Heldin CH, Landström M.

Sci Signal. 2017 Jul 4;10(486). pii: eaal4186. doi: 10.1126/scisignal.aal4186.

PMID:
28676490
17.

U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

Glimelius B, Melin B, Enblad G, Alafuzoff I, Beskow A, Ahlström H, Bill-Axelson A, Birgisson H, Björ O, Edqvist PH, Hansson T, Helleday T, Hellman P, Henriksson K, Hesselager G, Hultdin M, Häggman M, Höglund M, Jonsson H, Larsson C, Lindman H, Ljuslinder I, Mindus S, Nygren P, Pontén F, Riklund K, Rosenquist R, Sandin F, Schwenk JM, Stenling R, Stålberg K, Stålberg P, Sundström C, Thellenberg Karlsson C, Westermark B, Bergh A, Claesson-Welsh L, Palmqvist R, Sjöblom T.

Acta Oncol. 2018 Feb;57(2):187-194. doi: 10.1080/0284186X.2017.1337926. Epub 2017 Jun 20.

PMID:
28631533
18.

Metastatic spinal cord compression as the first sign of malignancy.

Wänman J, Grabowski P, Nyström H, Gustafsson P, Bergh A, Widmark A, Crnalic S.

Acta Orthop. 2017 Aug;88(4):457-462. doi: 10.1080/17453674.2017.1319179. Epub 2017 May 11.

19.

Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis.

Strömvall K, Thysell E, Halin Bergström S, Bergh A.

PLoS One. 2017 May 4;12(5):e0176679. doi: 10.1371/journal.pone.0176679. eCollection 2017.

20.

Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone.

Nordstrand A, Bergström SH, Thysell E, Bovinder-Ylitalo E, Lerner UH, Widmark A, Bergh A, Wikström P.

Clin Exp Metastasis. 2017 Apr;34(3-4):261-271. doi: 10.1007/s10585-017-9848-8. Epub 2017 Apr 26.

Supplemental Content

Loading ...
Support Center